The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders

American Journal of Clinical Pathology

Volumn 127, Issue 6, 2007, Pages 881-886

  Morice, William G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Immunophenotype; Lymphoproliferative disorders; Natural killer cells

Indexed keywords

ANTIBODY; CD16 ANTIGEN; CD161 ANTIGEN; CD16A ANTIGEN; CD16B ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; HLA E ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2A; T LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; CELL ACTIVATION; CLINICAL LABORATORY; CONFERENCE PAPER; CYTOTOXIC T LYMPHOCYTE; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION; CELL LINEAGE; FLOW CYTOMETRY; IMMUNOLOGY; PATHOLOGY;

ANTIGENS, CD; CELL LINEAGE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MARKERS, BIOLOGICAL;

EID: 34250660540     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/Q49CRJ030L22MHLF     Document Type: Conference Paper

References (28)

1. Ortaldo JR, Oldham RK, Cannon GC, et al. Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J Natl Cancer Inst. 1977;59:77-82.
2. Matthews N, Maclaurin BP, Clarke GN. Characterization of the normal lymphocyte population cytolytic to Burkitt's lymphoma cells of the EB2 cell line. Aust J Exp Biol Med Sci. 1976;53:389-398.
3. Takasugi M, Mickey MR, Terasaki PI. Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res. 1973;33:2898-2902.
4. Lotzova E, Ades EW. Natural killer cells: definition, heterogeneity, lytic mechanism, functions and clinical application: highlights of the Fifth International Workshop on natural killer cells, Hilton Head Island, NC, March 1988. Nat Immun Cell Growth Regul. 1989;8:1-9.
5. Lanier LL, Phillips JH, Hackett J Jr, et al. Natural killer cells: definition of a cell type rather than a function. J Immunol. 1986;137:2735-2739.
6. Lanier LL, Spits H, Phillips JH. The developmental relationship between NK cells and T cells. Immunol Today. 1992;13:392-395.
7. Anderson P, Caligiuri M, Ritz J, et al. CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex. Nature. 1989;341:159-162.
8. Phillips JH, Hori T, Nagler A, et al. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon, delta proteins. J Exp Med. 1992;175:1055-1066.
9. Lanier LL, Ruitenberg JJ, Phillips JH. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol. 1988;141:3478-3485.
10. Farag SS, Caligiuri MA. Human natural killer cell development and biology. Blood Rev. 2006;20:123-137.
11. Lanier LL, Le AM, Civin CI, et al. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol. 1986;136:4480-4486.
12. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981;127:1024-1029.
13. Tarazona R, DelaRosa O, Alonso C, et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2000;121:77-88.
14. Morice WG, Kurtin PJ, Leibson PJ, et al. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol. 2003;120:1026-1036.
15. Lundell R, Hartung L, Hill S, et al. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol. 2005;124:937-946.
16. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
17. Zambello R, Trentin L, Ciccone E, et al. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood. 1993;81:2381-2385.
18. Ljunggren HG, Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
19. Lanier LL. NK cell receptors. Annu Rev Immunol. 1998;16:359-393.
20. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol. 2004;4:190-198.
21. Leibson PJ. Cytotoxic lymphocyte recognition of HLA-E: utilizing a nonclassical window to peer into classical MHC. Immunity. 1998;9:289-294.
22. Hoffmann T, De Libero G, Colonna M, et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol. 2000;110:525-536.
23. Lin CW, Yang JY, Chuang YC, et al. Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor gamma rearrangement as evidence of mixed NK/T-cell differentiation in a subset of sinonasal lymphomas. Lab Invest. 2003;83:55-64.
24. Haedicke W, Ho FC, Chott A, et al. Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood. 2000;95:3628-3630.
25. Pascal V, Schleinitz N, Brunet C, et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur J Immunol. 2004;34:2930-2940.
26. Epling-Burnette PK, Painter JS, Chaurasia P, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood. 2004;103:3431-3439.
27. Lin CW, Chen YH, Chuang YC, et al. CD94 transcripts imply a better prognosis in nasal-type extranodal NK/T-cell lymphoma. Blood. 2003;102:2623-2631.
28. Warren HS, Christiansen FT, Witt CS. Functional inhibitory human leucocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis. Br J Haematol. 2003;121:793-804.